IMO, it's positive that a Type C meeting was granted and neutral-positive that IXC requested a Type B and were granted a Type C.
I'm leaning towards this being great news for the reasons outlined by @jellyroll. I don't necessarily agree that WRO is a bad thing in the current climate. It could very well mean that this is a straightforward case, given the Type 2 data, detailed statistical plan and EMA advice. Thus, IXC may only require written responses without additional guidance.
I also think the share price has factored in much of the worst case scenario - i.e., two trials are required by the FDA. I don't expect the SP to touch $0.40, but I guess anything is possible. Nothing about the market makes sense today.
@ralom - agree that it's frustrating, but we'll soon find out the reasons for the delay. This quarter is going to be a big one.
- Forums
- ASX - By Stock
- Ann: Invex Granted Type C Meeting with FDA
IMO, it's positive that a Type C meeting was granted and...
-
- There are more pages in this discussion • 118 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IXC (ASX) to my watchlist
(20min delay)
|
|||||
Last
6.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.960M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 100000 | 6.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.8¢ | 10000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 100000 | 0.062 |
1 | 15500 | 0.061 |
1 | 150000 | 0.060 |
1 | 100000 | 0.052 |
1 | 60001 | 0.041 |
Price($) | Vol. | No. |
---|---|---|
0.068 | 10000 | 1 |
0.069 | 16500 | 1 |
0.070 | 40000 | 1 |
0.076 | 888 | 1 |
0.083 | 4000 | 1 |
Last trade - 16.12pm 12/07/2024 (20 minute delay) ? |
Featured News
IXC (ASX) Chart |
Day chart unavailable